Sangamo Therapeutics Inc. buy Wells Fargo & Company
Start price
10.08.23
/
50%
€0.99
Target price
10.08.24
€3.63
Performance (%)
-45.41%
Price
12:42
€0.54
Summary
This prediction is currently active. Massive losses of -45.41% have been the result for the BUY prediction by Wells_Fargo___Compan. This prediction currently runs until 10.08.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Sangamo Therapeutics Inc. | -9.686% | -9.686% |
iShares Core DAX® | -0.683% | 1.890% |
iShares Nasdaq 100 | 0.335% | 4.631% |
iShares Nikkei 225® | -1.486% | -2.361% |
iShares S&P 500 | -0.523% | 2.324% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Wells Fargo & Company from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat